Illini, O.; Fabikan, H.; Hochmair, M.J.; Weinlinger, C.; Krenbek, D.; Brcic, L.; Setinek, U.; Terbuch, A.; Absenger, G.; Konjić, S.;
et al. Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study. J. Clin. Med. 2022, 11, 4098.
https://doi.org/10.3390/jcm11144098
AMA Style
Illini O, Fabikan H, Hochmair MJ, Weinlinger C, Krenbek D, Brcic L, Setinek U, Terbuch A, Absenger G, Konjić S,
et al. Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study. Journal of Clinical Medicine. 2022; 11(14):4098.
https://doi.org/10.3390/jcm11144098
Chicago/Turabian Style
Illini, Oliver, Hannah Fabikan, Maximilian Johannes Hochmair, Christoph Weinlinger, Dagmar Krenbek, Luka Brcic, Ulrike Setinek, Angelika Terbuch, Gudrun Absenger, Selma Konjić,
and et al. 2022. "Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study" Journal of Clinical Medicine 11, no. 14: 4098.
https://doi.org/10.3390/jcm11144098
APA Style
Illini, O., Fabikan, H., Hochmair, M. J., Weinlinger, C., Krenbek, D., Brcic, L., Setinek, U., Terbuch, A., Absenger, G., Konjić, S., & Valipour, A.
(2022). Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study. Journal of Clinical Medicine, 11(14), 4098.
https://doi.org/10.3390/jcm11144098
